chart software, version 5.0 Search Results


bio 1d software  (VILBER GmbH)
98
VILBER GmbH bio 1d software
Bio 1d Software, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bio 1d software/product/VILBER GmbH
Average 98 stars, based on 1 article reviews
bio 1d software - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier
tmz  (Selleck Chemicals)
94
Selleck Chemicals tmz
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Tmz, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tmz/product/Selleck Chemicals
Average 94 stars, based on 1 article reviews
tmz - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
labsolutions insight software version 3 50sp2  (Shimadzu Corporation)
99
Shimadzu Corporation labsolutions insight software version 3 50sp2
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Labsolutions Insight Software Version 3 50sp2, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labsolutions insight software version 3 50sp2/product/Shimadzu Corporation
Average 99 stars, based on 1 article reviews
labsolutions insight software version 3 50sp2 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
aida software version 4.50.010  (Raytest GmbH)
90
Raytest GmbH aida software version 4.50.010
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Aida Software Version 4.50.010, supplied by Raytest GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aida software version 4.50.010/product/Raytest GmbH
Average 90 stars, based on 1 article reviews
aida software version 4.50.010 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ic50 value  (GraphPad Software Inc)
90
GraphPad Software Inc ic50 value
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Ic50 Value, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ic50 value/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
ic50 value - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
non-linear regression curve fit  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression curve fit
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Non Linear Regression Curve Fit, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression curve fit/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression curve fit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
graphpad prism software  (GraphPad Software Inc)
90
GraphPad Software Inc graphpad prism software
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Graphpad Prism Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
prism version 5.0 software  (GraphPad Software Inc)
90
GraphPad Software Inc prism version 5.0 software
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Prism Version 5.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism version 5.0 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism version 5.0 software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
® version 12.3  (MedCalc Software Ltd)
90
MedCalc Software Ltd ® version 12.3
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
® Version 12.3, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/® version 12.3/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
® version 12.3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
living image software  (Revvity)
96
Revvity living image software
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Living Image Software, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/living image software/product/Revvity
Average 96 stars, based on 1 article reviews
living image software - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
peak able-based leco chromatof® software version 4.50  (LECO Corporation)
90
LECO Corporation peak able-based leco chromatof® software version 4.50
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Peak Able Based Leco Chromatof® Software Version 4.50, supplied by LECO Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peak able-based leco chromatof® software version 4.50/product/LECO Corporation
Average 90 stars, based on 1 article reviews
peak able-based leco chromatof® software version 4.50 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
leco chromatof software  (LECO Corporation)
90
LECO Corporation leco chromatof software
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Leco Chromatof Software, supplied by LECO Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leco chromatof software/product/LECO Corporation
Average 90 stars, based on 1 article reviews
leco chromatof software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to TMZ (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination with DMSO or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Article Title: HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion.

doi: 10.1016/j.ymthe.2022.02.009

Figure Lengend Snippet: Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to TMZ (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination with DMSO or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)

Article Snippet: TMZ (5 mg/mL in 20% DMSO) was administered by oral gavage and onalespib (6 mg/mL in 15% SelleckChem Captisol-S4592 in water) by tail vein injection given on the days and in the concentrations indicated in the Figures 7A and S6B) schematic overview.

Techniques: Software, Stable Transfection, Expressing